Monthly Prescribing Reference4 天
Aucatzyl Approved for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in ...
PMLiVE4 天
FDA approves Autolus Therapeutics’ Aucatzyl to treat acute lymphoblastic leukaemia
The US Food and Drug Administration (FDA) has approved Autolus Therapeutics’ Aucatzyl (obecabtagene autoleucel) to treat ...